CryoPort Inc

CryoPort Inc

CYRX

Get informed when a big investor buys or sells

+ Follow
Market Cap$790.81M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CryoPort IncCryoPort Inc10.1-16%5.50.5
$15.25

Target Price by Analysts

7.6% downsideCryoPort Target Price DetailsTarget Price
$-4.02

Current Fair Value

124.4% downside

Overvalued by 124.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$790.81 Million
Enterprise Value$750.70 Million
Dividend Yield$- (-)
Earnings per Share$1.4
Beta1.75
Outstanding Shares49,897,817

Return

Return on Equity15.59%ROE
Return on Assets10.10%
Return on Invested Capital-7.57%

Valuation & Multiples

P/E Ratio10.15P/E Ratio
PEG-31.18PEG
Price to Sales5.5Price to Sales
Price to Book Ratio1.83Price to Book Ratio
Enterprise Value to Revenue4.1
Enterprise Value to EBIT-18.41
Enterprise Value to Net Income9
Total Debt to Enterprise0.31
Debt to Equity0.47Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 6, 2026
EPS Estimate
$-0.20
Average shareholder expectation
Revenue Estimate
$44.87 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 4, 2026
EPS Estimate
$-0.19
Average shareholder expectation
Revenue Estimate
$48.20 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1449 1.15%
Total Calls1,789,300 36.30%
Total Puts259,200 48.03%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %91.38% 1.75%
Total Invested$378.86M 12.16%
Investors Holding172 6.00%

ESG Score

No data

About CryoPort Inc

Relevant Senate Committees

Finance

Controls taxation, trade, and entitlement spending (e.g., Medicare/Medicaid). Tax policy directly impacts corporate profitability, and Medicare/Medicaid coverage and pricing policies are major drivers of demand for medical instruments.

Appropriations

Allocates discretionary federal spending. Its subcommittees determine precise funding for healthcare programs, medical research, and government purchases, directly affecting demand and revenue streams for medical device companies.

Health, Education, Labor, and Pensions

Directly regulates the FDA (medical device approval and oversight), NIH (research funding), and labor laws, all of which are central to CryoPort's operations, product development, and manufacturing costs.

Judiciary

Oversees antitrust laws and intellectual property. Patent protection is critical for medical device manufacturers, and antitrust enforcement can impact M&A activity in the sector.

Veterans' Affairs

Oversees the Department of Veterans Affairs. Funding decisions directly impact government healthcare contractors, making it a crucial committee if CryoPort supplies medical devices to VA hospitals.